We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Orders AbbVie to Stop Recruiting in Myeloma Trial After Deaths Spike
FDA Orders AbbVie to Stop Recruiting in Myeloma Trial After Deaths Spike
The FDA has ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto, the company announced Wednesday.